FDA Investigated Recalled Glutathione Injections
The FDA identified dangerous bacterial contamination in compounded glutathione products linked to recent patient reactions.
Updated on Sept. 26, 2026 in Alternative Medicine
Live Poll
Do you trust that health supplements marketed for cosmetic purposes are safe to use?
In August 2026, the FDA launched an investigation following reports of at least 30 patients who experienced adverse reactions after receiving compounded intravenous glutathione. The regulatory action followed the identification of elevated bacterial endotoxin levels in products sold by several compounding pharmacies.
Why it matters
The investigation highlights significant safety risks associated with compounded medicines, which do not undergo the same rigorous FDA premarket approval process as standard medications. Because some recalled products used ingredients labeled for dietary supplements rather than injectables, they posed severe risks of infection and systemic shock.
The FDA investigation centers on reports of at least 30 patients who suffered adverse reactions after receiving compounded injectable glutathione. Testing confirmed these products contained high levels of bacterial endotoxins, which were traced back to non-sterile ingredients.
The players
FDA
The federal agency responsible for protecting public health by ensuring the safety and efficacy of human drugs and biological products.
Victory Medical Center Pharmacy
A pharmacy that issued a recall for specific lots of compounded glutathione due to safety concerns.
Optimal Balance Pharmacy
A pharmacy that initiated a recall of compounded glutathione distributed across multiple states.
Centric Compounding
A pharmacy that recalled six lots of various injectable products, including glutathione, Myers' Cocktail, and Tri-Immune Boost.
The details
The health risk stems from the use of dietary supplement-grade ingredients to create medications intended for intravenous administration. When injected, these contaminated substances introduce bacterial endotoxins directly into the bloodstream. These toxins can trigger an aggressive immune response, potentially resulting in inflammation, dangerously low blood pressure, septic shock, and, in severe instances, death.
Timeline
August 2026: The FDA announced an investigation into adverse glutathione events.
September 2026: An article regarding these glutathione safety alarms was published.
Health Landscape
This investigation exposes the significant safety gaps inherent in the current regulatory framework for compounded medications. It highlights the contrast between these products and traditional drugs, which must meet stringent manufacturing and sterility standards to ensure patient safety.
Patients who have received injectable glutathione or similar compounded therapies should monitor for signs of fever, inflammation, or rapid drops in blood pressure and seek immediate care if they occur. It is essential to discuss the source and sterility of any non-FDA approved injectable with your doctor before proceeding.
The takeaway
Injectable glutathione is not a standardized medication, and products produced by compounding pharmacies carry risks that standard pharmaceuticals do not. Always confirm with your physician that any injectable treatment is FDA-approved and sourced from a licensed, reputable facility.
Further reading
For more on the risks of non-FDA approved treatments, visit the Alternative Medicine section.
Source note: This article includes information reported by Medindia.
Live Poll
Do you trust that health supplements marketed for cosmetic purposes are safe to use?
